Conditions & Recovery · ScienceDaily Chronic Illness · September 21, 2026

Stopping Ozempic may raise heart attack and stroke risk

A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.

Originally published by ScienceDaily Chronic Illness. We curate and add context; they did the reporting.

Related learning